JPS4920317A - - Google Patents
Info
- Publication number
- JPS4920317A JPS4920317A JP47090523A JP9052372A JPS4920317A JP S4920317 A JPS4920317 A JP S4920317A JP 47090523 A JP47090523 A JP 47090523A JP 9052372 A JP9052372 A JP 9052372A JP S4920317 A JPS4920317 A JP S4920317A
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
- C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
- C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
- C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
- C07H15/236—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2 a saccharide radical being substituted by an alkylamino radical in position 3 and by two substituents different from hydrogen in position 4, e.g. gentamicin complex, sisomicin, verdamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
- C07K7/62—Polymyxins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Materials For Medical Uses (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24746672A | 1972-04-25 | 1972-04-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS4920317A true JPS4920317A (enExample) | 1974-02-22 |
Family
ID=22935052
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP47090523A Pending JPS4920317A (enExample) | 1972-04-25 | 1972-09-11 |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JPS4920317A (enExample) |
| CA (1) | CA950831A (enExample) |
| CH (1) | CH553815A (enExample) |
| DE (1) | DE2301633A1 (enExample) |
| FR (1) | FR2186230B1 (enExample) |
| GB (1) | GB1400464A (enExample) |
| ZA (1) | ZA723917B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0115001B1 (de) * | 1982-12-28 | 1988-06-15 | Bayer Ag | Stabile Aminoglykosid-Penicillin-Injektionsformulierungen |
| AUPN771596A0 (en) | 1996-01-25 | 1996-02-15 | Mclean, Allan Joseph | Methods of and compositions for potentiating the action of agents active on cell-wall sites of susceptible bacteria |
| CN1225583A (zh) * | 1996-07-16 | 1999-08-11 | 吉斯特-布罗卡迪斯有限公司 | 无有机溶剂的β－内酰胺颗粒 |
| IS6390A (is) | 2001-08-31 | 2003-03-03 | Heraeus Kulzer Gmbh & Co. Kg | Reynsla af sýklalyfjahúðun skrokka sem í eru örholrými, þannig húðuðum skrokkum og einnig af notkunþeirra |
| IS6389A (is) | 2001-08-31 | 2003-03-03 | Heraeus Kulzer Gmbh & Co. Kg | Reynsla af sýklalyfjahúðun skrokka, sem í eru örholrými, og einnig af þannig húðuðum skrokkum og notkun þeirra |
| DE10227935B4 (de) | 2002-06-21 | 2007-10-04 | Heraeus Kulzer Gmbh | Verfahren zur Herstellung einer antibiotische Beschichtung von porösen Körpern sowie Verwendung |
| US8106040B2 (en) | 2006-09-26 | 2012-01-31 | Taro Pharmaceuticals North America, Inc. | Stabilizing compositions for antibiotics and methods of use |
| US10682360B2 (en) | 2014-01-27 | 2020-06-16 | Susanne GARDNER | Antimicrobial formulations and applications thereof |
| WO2017019943A1 (en) * | 2015-07-29 | 2017-02-02 | Susanne Gardner | Antimicrobial formulations and applications thereof |
-
1972
- 1972-06-02 CA CA143,773,A patent/CA950831A/en not_active Expired
- 1972-06-06 GB GB2631872A patent/GB1400464A/en not_active Expired
- 1972-06-08 ZA ZA723917A patent/ZA723917B/xx unknown
- 1972-08-17 FR FR7229465A patent/FR2186230B1/fr not_active Expired
- 1972-09-11 JP JP47090523A patent/JPS4920317A/ja active Pending
- 1972-10-03 CH CH1439272A patent/CH553815A/fr not_active IP Right Cessation
-
1973
- 1973-01-13 DE DE2301633A patent/DE2301633A1/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA950831A (en) | 1974-07-09 |
| DE2301633A1 (de) | 1973-11-08 |
| GB1400464A (en) | 1975-07-16 |
| FR2186230B1 (enExample) | 1976-07-02 |
| FR2186230A1 (enExample) | 1974-01-11 |
| ZA723917B (en) | 1973-07-25 |
| CH553815A (fr) | 1974-09-13 |